S 432

ENROLLED
2026 Legislature  CS for SB 432, 1st Engrossed
  2026432er
1
2An act relating to intoxicating substances; providing
3a short title; creating s. 569.216, F.S.; prohibiting
4tobacco or nicotine dealers, or their agents or
5employees, from possessing, selling, possessing with
6intent to sell, delivering, or giving, directly or
7indirectly, nitrous oxide on or from the dealer’s
8licensed premises; providing criminal penalties;
9providing applicability; providing construction;
10requiring the Department of Business and Professional
11Regulation to adopt rules; amending s. 893.03, F.S.;
12excepting from the list of Schedule I controlled
13substances certain xylazine animal drug products
14approved by the United States Food and Drug
15Administration and used for certain purposes; amending
16s. 893.13, F.S.; providing criminal penalties and
17requiring a mandatory minimum term of imprisonment if
18a person sells, manufactures, or delivers or possesses
19with intent to sell, manufacture, or deliver xylazine;
20amending s. 893.135, F.S.; creating the offense of
21trafficking in xylazine; providing criminal penalties
22and requiring a mandatory minimum term of imprisonment
23and fines based on the quantity of the controlled
24substance involved in the offense; providing effective
25dates.
26
27Be It Enacted by the Legislature of the State of Florida:
28
29Section 1. Section 2 of this act may be cited as “Meg’s
30Law.”
31Section 2. Section 569.216, Florida Statutes, is created to
32read:
33569.216 Prohibition on possessing, selling, delivering, or
34giving nitrous oxide; penalties; exceptions.—
35(1) It is unlawful for any dealer who is licensed or
36permitted under this chapter, or a dealer’s agent or employee,
37to possess, sell, possess with intent to sell, deliver, or give,
38directly or indirectly, nitrous oxide on or from the dealer’s
39licensed premises. A dealer or a dealer’s agent or employee who
40violates this subsection commits a felony of the third degree,
41punishable as provided in s. 775.082, s. 775.083, or s. 775.084.
42(2) This section does not apply to a grocery store or
43supermarket, as licensed or permitted by the Department of
44Agriculture and Consumer Services, but does apply to a
45convenience business, as defined by s. 812.171.
46(3) This section does not prohibit the possession, sale,
47delivery, or giving of a finished food product in which nitrous
48oxide is used solely as a propellant.
49(4) The Department of Business and Professional Regulation
50shall adopt rules regarding the possession, sale, delivery, or
51giving of nitrous oxide to prevent the use of nitrous oxide for
52inducing a condition of intoxication. Such rules may address
53products containing nitrous oxide and finished food products in
54which nitrous oxide is used solely as a propellant.
55Section 3. Effective July 1, 2026, paragraph (c) of
56subsection (1) of section 893.03, Florida Statutes, is amended
57to read:
58893.03 Standards and schedules.—The substances enumerated
59in this section are controlled by this chapter. The controlled
60substances listed or to be listed in Schedules I, II, III, IV,
61and V are included by whatever official, common, usual,
62chemical, trade name, or class designated. The provisions of
63this section shall not be construed to include within any of the
64schedules contained in this section any excluded drugs listed
65within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
66Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
67Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
68Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
69Anabolic Steroid Products.”
70(1) SCHEDULE I.—A substance in Schedule I has a high
71potential for abuse and has no currently accepted medical use in
72treatment in the United States and in its use under medical
73supervision does not meet accepted safety standards. The
74following substances are controlled in Schedule I:
75(c) Unless specifically excepted or unless listed in
76another schedule, any material, compound, mixture, or
77preparation that contains any quantity of the following
78hallucinogenic substances or that contains any of their salts,
79isomers, including optical, positional, or geometric isomers,
80homologues, nitrogen-heterocyclic analogs, esters, ethers, and
81salts of isomers, homologues, nitrogen-heterocyclic analogs,
82esters, or ethers, if the existence of such salts, isomers, and
83salts of isomers is possible within the specific chemical
84designation or class description:
851. Alpha-Ethyltryptamine.
862. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2
87oxazoline).
883. Aminorex (2-Amino-5-phenyl-2-oxazoline).
894. DOB (4-Bromo-2,5-dimethoxyamphetamine).
905. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
916. Bufotenine.
927. Cannabis.
938. Cathinone.
949. DET (Diethyltryptamine).
9510. 2,5-Dimethoxyamphetamine.
9611. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).
9712. DMT (Dimethyltryptamine).
9813. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine
99analog of phencyclidine).
10014. JB-318 (N-Ethyl-3-piperidyl benzilate).
10115. N-Ethylamphetamine.
10216. Fenethylline.
10317. 3,4-Methylenedioxy-N-hydroxyamphetamine.
10418. Ibogaine.
10519. LSD (Lysergic acid diethylamide).
10620. Mescaline.
10721. Methcathinone.
10822. 5-Methoxy-3,4-methylenedioxyamphetamine.
10923. PMA (4-Methoxyamphetamine).
11024. PMMA (4-Methoxymethamphetamine).
11125. DOM (4-Methyl-2,5-dimethoxyamphetamine).
11226. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
11327. MDA (3,4-Methylenedioxyamphetamine).
11428. JB-336 (N-Methyl-3-piperidyl benzilate).
11529. N,N-Dimethylamphetamine.
11630. Parahexyl.
11731. Peyote.
11832. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine
119analog of phencyclidine).
12033. Psilocybin.
12134. Psilocyn.
12235. Salvia divinorum, except for any drug product approved
123by the United States Food and Drug Administration which contains
124Salvia divinorum or its isomers, esters, ethers, salts, and
125salts of isomers, esters, and ethers, if the existence of such
126isomers, esters, ethers, and salts is possible within the
127specific chemical designation.
12836. Salvinorin A, except for any drug product approved by
129the United States Food and Drug Administration which contains
130Salvinorin A or its isomers, esters, ethers, salts, and salts of
131isomers, esters, and ethers, if the existence of such isomers,
132esters, ethers, and salts is possible within the specific
133chemical designation.
13437. Xylazine, except for a xylazine animal drug product
135approved by the United States Food and Drug Administration and
136the use of which conforms to the approved application or is
137authorized under 21 U.S.C. s. 360b(a)(4). The manufacture,
138importation, distribution, prescribing, or sale of xylazine for
139human use is not subject to this exception.
14038. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)
141(Thiophene analog of phencyclidine).
14239. 3,4,5-Trimethoxyamphetamine.
14340. Methylone (3,4-Methylenedioxymethcathinone).
14441. MDPV (3,4-Methylenedioxypyrovalerone).
14542. Methylmethcathinone.
14643. Methoxymethcathinone.
14744. Fluoromethcathinone.
14845. Methylethcathinone.
14946. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
150yl)phenol) and its dimethyloctyl (C8) homologue.
15147. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2
152methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].
15348. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
15449. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
15550. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
156naphthoyl)indole).
15751. BZP (Benzylpiperazine).
15852. Fluorophenylpiperazine.
15953. Methylphenylpiperazine.
16054. Chlorophenylpiperazine.
16155. Methoxyphenylpiperazine.
16256. DBZP (1,4-Dibenzylpiperazine).
16357. TFMPP (Trifluoromethylphenylpiperazine).
16458. MBDB (Methylbenzodioxolylbutanamine) or (3,4
165Methylenedioxy-N-methylbutanamine).
16659. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
16760. 5-Hydroxy-N-methyltryptamine.
16861. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
16962. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
17063. Methyltryptamine.
17164. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
17265. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
17366. Tyramine (4-Hydroxyphenethylamine).
17467. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
17568. DiPT (N,N-Diisopropyltryptamine).
17669. DPT (N,N-Dipropyltryptamine).
17770. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
17871. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
17972. DOI (4-Iodo-2,5-dimethoxyamphetamine).
18073. DOC (4-Chloro-2,5-dimethoxyamphetamine).
18174. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
18275. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
18376. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
18477. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
18578. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
18679. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
18780. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
18881. Butylone (3,4-Methylenedioxy-alpha
189methylaminobutyrophenone).
19082. Ethcathinone.
19183. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
19284. Naphyrone (Naphthylpyrovalerone).
19385. Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).
19486. 3,4-Methylenedioxy-N,N-diethylcathinone.
19587. 3,4-Methylenedioxy-propiophenone.
19688. 3,4-Methylenedioxy-alpha-bromopropiophenone.
19789. 3,4-Methylenedioxy-propiophenone-2-oxime.
19890. 3,4-Methylenedioxy-N-acetylcathinone.
19991. 3,4-Methylenedioxy-N-acetylmethcathinone.
20092. 3,4-Methylenedioxy-N-acetylethcathinone.
20193. Bromomethcathinone.
20294. Buphedrone (alpha-Methylamino-butyrophenone).
20395. Eutylone (3,4-Methylenedioxy-alpha
204ethylaminobutyrophenone).
20596. Dimethylcathinone.
20697. Dimethylmethcathinone.
20798. Pentylone (3,4-Methylenedioxy-alpha
208methylaminovalerophenone).
20999. MDPPP (3,4-Methylenedioxy-alpha
210pyrrolidinopropiophenone).
211100. MDPBP (3,4-Methylenedioxy-alpha
212pyrrolidinobutyrophenone).
213101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
214102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).
215103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
216(Benocyclidine).
217104. F-MABP (Fluoromethylaminobutyrophenone).
218105. MeO-PBP (Methoxypyrrolidinobutyrophenone).
219106. Et-PBP (Ethylpyrrolidinobutyrophenone).
220107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
221108. Me-EABP (Methylethylaminobutyrophenone).
222109. Etizolam.
223110. PPP (Pyrrolidinopropiophenone).
224111. PBP (Pyrrolidinobutyrophenone).
225112. PVP (Pyrrolidinovalerophenone) or
226(Pyrrolidinopentiophenone).
227113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).
228114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
229115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
230116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
231117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
232118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
233119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
234120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
235121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
2362-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
237122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
238123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
239124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
240125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
241126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
242127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
243128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
244129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
245130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
246(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
247ol).
248131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan
2492-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]
250methanol).
251132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1
252methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene
2531,4-dione).
254133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).
255134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)
256undecanamide).
257135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)
258undecanamide).
259136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2
260methyloctan-2-yl)phenol).
261137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
262138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
263139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
264140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2
265methoxyphenylacetyl)indole).
266141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4
267morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
268naphthalenylmethanone).
269142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4
270morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
271naphthalenylmethanone).
272143. Pentedrone (alpha-Methylaminovalerophenone).
273144. Fluoroamphetamine.
274145. Fluoromethamphetamine.
275146. Methoxetamine.
276147. Methiopropamine.
277148. Methylbuphedrone (Methyl-alpha
278methylaminobutyrophenone).
279149. APB ((2-Aminopropyl)benzofuran).
280150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).
281151. UR-144 (1-Pentyl-3-(2,2,3,3
282tetramethylcyclopropanoyl)indole).
283152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
284tetramethylcyclopropanoyl)indole).
285153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
286tetramethylcyclopropanoyl)indole).
287154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
288155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
289iodobenzoyl)indole).
290156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
291carboxamide).
292157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)
293cyclohexylcarbamate).
294158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,
295cyclohexyl ester).
296159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1
297benzoxazin-4-one).
298160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
299161. 2C-H (2,5-Dimethoxyphenethylamine).
300162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
301163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
302164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
303methoxybenzyl)]phenethylamine).
304165. MDMA (3,4-Methylenedioxymethamphetamine).
305166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
306167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
307carboxylate).
308168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
309carboxylate).
310169. Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
3113-carboxamide).
312170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
313pentylindazole-3-carboxamide).
314171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
315(4-fluorobenzyl)indazole-3-carboxamide).
316172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
3171-pentylindazole-3-carboxamide).
318173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
319yl)-1-(fluoropentyl)indole-3-carboxamide).
320174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
321methoxybenzyl)]phenethylamine).
322175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
323methoxybenzyl)]phenethylamine).
324176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
325(cyclohexylmethyl)indazole-3-carboxamide).
326177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
327carboxylate).
328178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
3293-carboxamide).
330179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
331(fluoropentyl)indazole-3-carboxamide).
332180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).
333181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl
3341,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
335182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9
336(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
337hexahydrobenzo[c]chromen-1-ol).
338183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9
339(hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
340hexahydrobenzo[c]chromen-1-ol).
341184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)
3426a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
343diol).
344185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6
345dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a
346tetrahydro-6aH-benzo[c]chromen-1-ol).
347186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl
3486a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
349187. MAPB ((2-Methylaminopropyl)benzofuran).
350188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).
351189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).
352190. Synthetic Cannabinoids.—Unless specifically excepted
353or unless listed in another schedule or contained within a
354pharmaceutical product approved by the United States Food and
355Drug Administration, any material, compound, mixture, or
356preparation that contains any quantity of a synthetic
357cannabinoid found to be in any of the following chemical class
358descriptions, or homologues, nitrogen-heterocyclic analogs,
359isomers (including optical, positional, or geometric), esters,
360ethers, salts, and salts of homologues, nitrogen-heterocyclic
361analogs, isomers, esters, or ethers, whenever the existence of
362such homologues, nitrogen-heterocyclic analogs, isomers, esters,
363ethers, salts, and salts of isomers, esters, or ethers is
364possible within the specific chemical class or designation.
365Since nomenclature of these synthetically produced cannabinoids
366is not internationally standardized and may continually evolve,
367these structures or the compounds of these structures shall be
368included under this subparagraph, regardless of their specific
369numerical designation of atomic positions covered, if it can be
370determined through a recognized method of scientific testing or
371analysis that the substance contains properties that fit within
372one or more of the following categories:
373a. Tetrahydrocannabinols.—Any tetrahydrocannabinols
374naturally contained in a plant of the genus Cannabis, the
375synthetic equivalents of the substances contained in the plant
376or in the resinous extracts of the genus Cannabis, or synthetic
377substances, derivatives, and their isomers with similar chemical
378structure and pharmacological activity, including, but not
379limited to, Delta 9 tetrahydrocannabinols and their optical
380isomers, Delta 8 tetrahydrocannabinols and their optical
381isomers, Delta 6a,10a tetrahydrocannabinols and their optical
382isomers, or any compound containing a tetrahydrobenzo[c]chromene
383structure with substitution at either or both the 3-position or
3849-position, with or without substitution at the 1-position with
385hydroxyl or alkoxy groups, including, but not limited to:
386(I) Tetrahydrocannabinol.
387(II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
388(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
389ol).
390(III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
391(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
392ol).
393(IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
394(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
395(V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
3962-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
397(VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan
3982-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
399(VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3
400dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
401(VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)
4026,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
403(IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl
4046a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
405(X) Parahexyl.
406b. Naphthoylindoles, Naphthoylindazoles,
407Naphthoylcarbazoles, Naphthylmethylindoles,
408Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any
409compound containing a naphthoylindole, naphthoylindazole,
410naphthoylcarbazole, naphthylmethylindole,
411naphthylmethylindazole, or naphthylmethylcarbazole structure,
412with or without substitution on the indole, indazole, or
413carbazole ring to any extent, whether or not substituted on the
414naphthyl ring to any extent, including, but not limited to:
415(I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
416(II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1
417naphthoyl)indole).
418(III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
419(IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).
420(V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
421(VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
422(VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
423(VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).
424(IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).
425(X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
426(XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
427(XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
428(XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
429(XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1
430naphthoyl)indole).
431(XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
432(XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
433(XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1
434naphthoyl)indole).
435(XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).
436(XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
437(XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).
438(XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
439(XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1
440naphthylmethyl]indole).
441(XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1
442naphthoyl)indole).
443(XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1
444naphthoyl)indole).
445(XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
446naphthoyl)indole).
447(XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
448(XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
449(XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
450(XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
451(XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
452(XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1
453naphthoyl)indole).
454(XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1
455naphthoyl)indole).
456(XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1
457naphthoyl)indole).
458(XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1
459naphthoyl)indole).
460(XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1
461naphthoyl)indole).
462(XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).
463(XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1
464naphthoyl)indazole).
465(XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1
466naphthoyl)indole).
467(XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1
468naphthoyl)indole).
469(XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).
470(XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1
471naphthoyl)carbazole).
472c. Naphthoylpyrroles.—Any compound containing a
473naphthoylpyrrole structure, with or without substitution on the
474pyrrole ring to any extent, whether or not substituted on the
475naphthyl ring to any extent, including, but not limited to:
476(I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).
477(II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).
478(III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
479(IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
480(V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
481(VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1
482naphthoyl)pyrrole).
483(VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1
484naphthoyl)pyrrole).
485(VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1
486naphthoyl)pyrrole).
487(IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1
488naphthoyl)pyrrole).
489(X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1
490naphthoyl)pyrrole).
491d. Naphthylmethylenindenes.—Any compound containing a
492naphthylmethylenindene structure, with or without substitution
493at the 3-position of the indene ring to any extent, whether or
494not substituted on the naphthyl ring to any extent, including,
495but not limited to, JWH-176 (3-Pentyl-1
496(naphthylmethylene)indene).
497e. Phenylacetylindoles and Phenylacetylindazoles.—Any
498compound containing a phenylacetylindole or phenylacetylindazole
499structure, with or without substitution on the indole or
500indazole ring to any extent, whether or not substituted on the
501phenyl ring to any extent, including, but not limited to:
502(I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
503(II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
504(III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
505(IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
506(V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
507(VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
508(VII) Cannabipiperidiethanone.
509(VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2
510methoxyphenylacetyl)indole).
511f. Cyclohexylphenols.—Any compound containing a
512cyclohexylphenol structure, with or without substitution at the
5135-position of the phenolic ring to any extent, whether or not
514substituted on the cyclohexyl ring to any extent, including, but
515not limited to:
516(I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
517yl)phenol).
518(II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
519homologue).
520(III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2
521methyloctan-2-yl)phenol).
522g. Benzoylindoles and Benzoylindazoles.—Any compound
523containing a benzoylindole or benzoylindazole structure, with or
524without substitution on the indole or indazole ring to any
525extent, whether or not substituted on the phenyl ring to any
526extent, including, but not limited to:
527(I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).
528(II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
529(III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
530iodo-5-nitrobenzoyl)indole).
531(IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4
532methoxybenzoyl)indole).
533(V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
534iodobenzoyl)indole).
535(VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
536(VII) RCS-4 C4 homologue (1-Butyl-3-(4
537methoxybenzoyl)indole).
538(VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo
5393-(4-methoxybenzoyl)indole).
540h. Tetramethylcyclopropanoylindoles and
541Tetramethylcyclopropanoylindazoles.—Any compound containing a
542tetramethylcyclopropanoylindole or
543tetramethylcyclopropanoylindazole structure, with or without
544substitution on the indole or indazole ring to any extent,
545whether or not substituted on the tetramethylcyclopropyl group
546to any extent, including, but not limited to:
547(I) UR-144 (1-Pentyl-3-(2,2,3,3
548tetramethylcyclopropanoyl)indole).
549(II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
550tetramethylcyclopropanoyl)indole).
551(III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
552tetramethylcyclopropanoyl)indole).
553(IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3
554tetramethylcyclopropanoyl)indole).
555(V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3
556tetramethylcyclopropanoyl)indole).
557(VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3
558tetramethylcyclopropanoyl)indole).
559(VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3
560tetramethylcyclopropanoyl)indole).
561(VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3
562tetramethylcyclopropanoyl)indazole).
563(IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3
564tetramethylcyclopropanoyl)indole).
565(X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3
566tetramethylcyclopropanoyl)indole).
567i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole
568carboxamides, and Adamantylindazole carboxamides.—Any compound
569containing an adamantoyl indole, adamantoyl indazole, adamantyl
570indole carboxamide, or adamantyl indazole carboxamide structure,
571with or without substitution on the indole or indazole ring to
572any extent, whether or not substituted on the adamantyl ring to
573any extent, including, but not limited to:
574(I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
575(II) Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
5763-carboxamide).
577(III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
578carboxamide).
579(IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1
580adamantoyl)indole).
581(V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).
582(VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).
583(VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1
584adamantoyl)indole).
585j. Quinolinylindolecarboxylates,
586Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,
587and Quinolinylindazolecarboxamides.—Any compound containing a
588quinolinylindole carboxylate, quinolinylindazole carboxylate,
589isoquinolinylindole carboxylate, isoquinolinylindazole
590carboxylate, quinolinylindole carboxamide, quinolinylindazole
591carboxamide, isoquinolinylindole carboxamide, or
592isoquinolinylindazole carboxamide structure, with or without
593substitution on the indole or indazole ring to any extent,
594whether or not substituted on the quinoline or isoquinoline ring
595to any extent, including, but not limited to:
596(I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
597(II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
598carboxylate).
599(III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
600carboxylate).
601(IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
602carboxylate).
603(V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).
604(VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole
6053-carboxylate).
606(VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole
6073-carboxylate).
608(VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).
609(IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3
610carboxamide).
611k. Naphthylindolecarboxylates and
612Naphthylindazolecarboxylates.—Any compound containing a
613naphthylindole carboxylate or naphthylindazole carboxylate
614structure, with or without substitution on the indole or
615indazole ring to any extent, whether or not substituted on the
616naphthyl ring to any extent, including, but not limited to:
617(I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3
618carboxylate).
619(II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3
620carboxylate).
621(III) Fluoro SDB-005 (1-Naphthalenyl 1
622(fluoropentyl)indazole-3-carboxylate).
623(IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3
624carboxylate).
625(V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3
626carboxylate).
627l. Naphthylindole carboxamides and Naphthylindazole
628carboxamides.—Any compound containing a naphthylindole
629carboxamide or naphthylindazole carboxamide structure, with or
630without substitution on the indole or indazole ring to any
631extent, whether or not substituted on the naphthyl ring to any
632extent, including, but not limited to:
633(I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).
634(II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
6353-carboxamide).
636(III) Chloro-NNEI (N-Naphthalen-1-yl 1
637(chloropentyl)indole-3-carboxamide).
638(IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3
639carboxamide).
640(V) Fluoro MN-18 (N-Naphthalen-1-yl 1
641(fluoropentyl)indazole-3-carboxamide).
642m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl
643indazole carboxamides, Alkylcarbonyl indole carboxylates, and
644Alkylcarbonyl indazole carboxylates.—Any compound containing an
645alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
6461-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3
647phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
648indole carboxamide, indazole carboxamide, indole carboxylate, or
649indazole carboxylate, with or without substitution on the indole
650or indazole ring to any extent, whether or not substituted on
651the alkylcarbonyl group to any extent, including, but not
652limited to:
653(I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1
654pentylindole-3-carboxamide).
655(II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
656yl)-1-(fluoropentyl)indole-3-carboxamide).
657(III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
658(fluoropentyl)indole-3-carboxamide).
659(IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
660pentylindazole-3-carboxamide).
661(V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)
6621-(fluoropentyl)indazole-3-carboxamide).
663(VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
6641-pentylindazole-3-carboxamide).
665(VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1
666oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
667(VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
668(4-fluorobenzyl)indazole-3-carboxamide).
669(IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
670yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
671(X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
672(cyclohexylmethyl)indazole-3-carboxamide).
673(XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
674(cyclohexylmethyl)indazole-3-carboxamide).
675(XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
676yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
677(XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
678pentylindazole-3-carboxamide).
679(XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
680(fluoropentyl)indazole-3-carboxamide).
681(XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4
682fluorobenzyl)indazole-3-carboxamide).
683(XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
6842-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
685(XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
6862-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
687(XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
6882-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
689(XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
690fluoropentyl)indole-3-carboxamide).
691(XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
692fluoropentyl)indazole-3-carboxamide).
693(XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1
694(cyclohexylmethyl)indazole-3-carboxamide).
695(XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4
696fluorobenzyl)indazole-3-carboxamide).
697(XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
6982-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
699n. Cumylindolecarboxamides and Cumylindazolecarboxamides.
700Any compound containing a N-(2-phenylpropan-2-yl) indole
701carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
702structure, with or without substitution on the indole or
703indazole ring to any extent, whether or not substituted on the
704phenyl ring of the cumyl group to any extent, including, but not
705limited to:
706(I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3
707carboxamide).
708(II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1
709(fluoropentyl)indole-3-carboxamide).
710o. Other Synthetic Cannabinoids.—Any material, compound,
711mixture, or preparation that contains any quantity of a
712Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
713(I) With or without modification or replacement of a
714carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
715between either two core rings, or linkage between a core ring
716and group structure, with or without the addition of a carbon or
717replacement of a carbon;
718(II) With or without replacement of a core ring or group
719structure, whether or not substituted on the ring or group
720structures to any extent; and
721(III) Is a cannabinoid receptor agonist, unless
722specifically excepted or unless listed in another schedule or
723contained within a pharmaceutical product approved by the United
724States Food and Drug Administration.
725191. Substituted Cathinones.—Unless specifically excepted,
726listed in another schedule, or contained within a pharmaceutical
727product approved by the United States Food and Drug
728Administration, any material, compound, mixture, or preparation,
729including its salts, isomers, esters, or ethers, and salts of
730isomers, esters, or ethers, whenever the existence of such salts
731is possible within any of the following specific chemical
732designations:
733a. Any compound containing a 2-amino-1-phenyl-1-propanone
734structure;
735b. Any compound containing a 2-amino-1-naphthyl-1-propanone
736structure; or
737c. Any compound containing a 2-amino-1-thiophenyl-1
738propanone structure,
739
740whether or not the compound is further modified:
741(I) With or without substitution on the ring system to any
742extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,
743haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused
744dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide
745substituents;
746(II) With or without substitution at the 3-propanone
747position with an alkyl substituent or removal of the methyl
748group at the 3-propanone position;
749(III) With or without substitution at the 2-amino nitrogen
750atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or
751not further substituted in the ring system; or
752(IV) With or without inclusion of the 2-amino nitrogen atom
753in a cyclic structure, including, but not limited to:
754(A) Methcathinone.
755(B) Ethcathinone.
756(C) Methylone (3,4-Methylenedioxymethcathinone).
757(D) 2,3-Methylenedioxymethcathinone.
758(E) MDPV (3,4-Methylenedioxypyrovalerone).
759(F) Methylmethcathinone.
760(G) Methoxymethcathinone.
761(H) Fluoromethcathinone.
762(I) Methylethcathinone.
763(J) Butylone (3,4-Methylenedioxy-alpha
764methylaminobutyrophenone).
765(K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
766(L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).
767(M) Naphyrone (Naphthylpyrovalerone).
768(N) Bromomethcathinone.
769(O) Buphedrone (alpha-Methylaminobutyrophenone).
770(P) Eutylone (3,4-Methylenedioxy-alpha
771ethylaminobutyrophenone).
772(Q) Dimethylcathinone.
773(R) Dimethylmethcathinone.
774(S) Pentylone (3,4-Methylenedioxy-alpha
775methylaminovalerophenone).
776(T) Pentedrone (alpha-Methylaminovalerophenone).
777(U) MDPPP (3,4-Methylenedioxy-alpha
778pyrrolidinopropiophenone).
779(V) MDPBP (3,4-Methylenedioxy-alpha
780pyrrolidinobutyrophenone).
781(W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).
782(X) PPP (Pyrrolidinopropiophenone).
783(Y) PVP (Pyrrolidinovalerophenone) or
784(Pyrrolidinopentiophenone).
785(Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
786(AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).
787(BB) F-MABP (Fluoromethylaminobutyrophenone).
788(CC) Me-EABP (Methylethylaminobutyrophenone).
789(DD) PBP (Pyrrolidinobutyrophenone).
790(EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).
791(FF) Et-PBP (Ethylpyrrolidinobutyrophenone).
792(GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
793(HH) Dimethylone (3,4-Methylenedioxy-N,N
794dimethylcathinone).
795(II) 3,4-Methylenedioxy-N,N-diethylcathinone.
796(JJ) 3,4-Methylenedioxy-N-acetylcathinone.
797(KK) 3,4-Methylenedioxy-N-acetylmethcathinone.
798(LL) 3,4-Methylenedioxy-N-acetylethcathinone.
799(MM) Methylbuphedrone (Methyl-alpha
800methylaminobutyrophenone).
801(NN) Methyl-alpha-methylaminohexanophenone.
802(OO) N-Ethyl-N-methylcathinone.
803(PP) PHP (Pyrrolidinohexanophenone).
804(QQ) PV8 (Pyrrolidinoheptanophenone).
805(RR) Chloromethcathinone.
806(SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
807192. Substituted Phenethylamines.—Unless specifically
808excepted or unless listed in another schedule, or contained
809within a pharmaceutical product approved by the United States
810Food and Drug Administration, any material, compound, mixture,
811or preparation, including its salts, isomers, esters, or ethers,
812and salts of isomers, esters, or ethers, whenever the existence
813of such salts is possible within any of the following specific
814chemical designations, any compound containing a phenethylamine
815structure, without a beta-keto group, and without a benzyl group
816attached to the amine group, whether or not the compound is
817further modified with or without substitution on the phenyl ring
818to any extent with alkyl, alkylthio, nitro, alkoxy, thio,
819halide, fused alkylenedioxy, fused furan, fused benzofuran,
820fused dihydrofuran, or fused tetrahydropyran substituents,
821whether or not further substituted on a ring to any extent, with
822or without substitution at the alpha or beta position by any
823alkyl substituent, with or without substitution at the nitrogen
824atom, and with or without inclusion of the 2-amino nitrogen atom
825in a cyclic structure, including, but not limited to:
826a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
827b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
828c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
829d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
830e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
831f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
832g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
833h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
834i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
835j. 2C-H (2,5-Dimethoxyphenethylamine).
836k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
837l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
838m. MDMA (3,4-Methylenedioxymethamphetamine).
839n. MBDB (Methylbenzodioxolylbutanamine) or (3,4
840Methylenedioxy-N-methylbutanamine).
841o. MDA (3,4-Methylenedioxyamphetamine).
842p. 2,5-Dimethoxyamphetamine.
843q. Fluoroamphetamine.
844r. Fluoromethamphetamine.
845s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
846t. DOB (4-Bromo-2,5-dimethoxyamphetamine).
847u. DOC (4-Chloro-2,5-dimethoxyamphetamine).
848v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).
849w. DOI (4-Iodo-2,5-dimethoxyamphetamine).
850x. DOM (4-Methyl-2,5-dimethoxyamphetamine).
851y. PMA (4-Methoxyamphetamine).
852z. N-Ethylamphetamine.
853aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.
854bb. 5-Methoxy-3,4-methylenedioxyamphetamine.
855cc. PMMA (4-Methoxymethamphetamine).
856dd. N,N-Dimethylamphetamine.
857ee. 3,4,5-Trimethoxyamphetamine.
858ff. 4-APB (4-(2-Aminopropyl)benzofuran).
859gg. 5-APB (5-(2-Aminopropyl)benzofuran).
860hh. 6-APB (6-(2-Aminopropyl)benzofuran).
861ii. 7-APB (7-(2-Aminopropyl)benzofuran).
862jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
863kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
864ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
865mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
866nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).
867oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).
868pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).
869qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).
870rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).
871ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3
872dihydrobenzofuran),
873
874which does not include phenethylamine, mescaline as described in
875subparagraph 20., substituted cathinones as described in
876subparagraph 191., N-Benzyl phenethylamine compounds as
877described in subparagraph 193., or methamphetamine as described
878in subparagraph (2)(c)5.
879193. N-Benzyl Phenethylamine Compounds.—Unless specifically
880excepted or unless listed in another schedule, or contained
881within a pharmaceutical product approved by the United States
882Food and Drug Administration, any material, compound, mixture,
883or preparation, including its salts, isomers, esters, or ethers,
884and salts of isomers, esters, or ethers, whenever the existence
885of such salts is possible within any of the following specific
886chemical designations, any compound containing a phenethylamine
887structure without a beta-keto group, with substitution on the
888nitrogen atom of the amino group with a benzyl substituent, with
889or without substitution on the phenyl or benzyl ring to any
890extent with alkyl, alkoxy, thio, alkylthio, halide, fused
891alkylenedioxy, fused furan, fused benzofuran, or fused
892tetrahydropyran substituents, whether or not further substituted
893on a ring to any extent, with or without substitution at the
894alpha position by any alkyl substituent, including, but not
895limited to:
896a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
897methoxybenzyl)]phenethylamine).
898b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2
899hydroxybenzyl)]phenethylamine).
900c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2
901fluorobenzyl)]phenethylamine).
902d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3
903methylenedioxybenzyl)]phenethylamine).
904e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
905methoxybenzyl)]phenethylamine).
906f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2
907hydroxybenzyl)]phenethylamine).
908g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2
909fluorobenzyl)]phenethylamine).
910h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3
911methylenedioxybenzyl)]phenethylamine).
912i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2
913methoxybenzyl)]phenethylamine).
914j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2
915methoxybenzyl)]phenethylamine).
916k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2
917methoxybenzyl)]phenethylamine).
918l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
919methoxybenzyl)]phenethylamine).
920m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2
921hydroxybenzyl)]phenethylamine).
922n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2
923fluorobenzyl)]phenethylamine).
924o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3
925methylenedioxybenzyl)]phenethylamine).
926p. 25H-NBOMe (2,5-Dimethoxy-[N-(2
927methoxybenzyl)]phenethylamine).
928q. 25H-NBOH (2,5-Dimethoxy-[N-(2
929hydroxybenzyl)]phenethylamine).
930r. 25H-NBF (2,5-Dimethoxy-[N-(2
931fluorobenzyl)]phenethylamine).
932s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2
933methoxybenzyl)]phenethylamine),
934
935which does not include substituted cathinones as described in
936subparagraph 191.
937194. Substituted Tryptamines.—Unless specifically excepted
938or unless listed in another schedule, or contained within a
939pharmaceutical product approved by the United States Food and
940Drug Administration, any material, compound, mixture, or
941preparation containing a 2-(1H-indol-3-yl)ethanamine, for
942example tryptamine, structure with or without mono- or di
943substitution of the amine nitrogen with alkyl or alkenyl groups,
944or by inclusion of the amino nitrogen atom in a cyclic
945structure, whether or not substituted at the alpha position with
946an alkyl group, whether or not substituted on the indole ring to
947any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy
948groups, including, but not limited to:
949a. Alpha-Ethyltryptamine.
950b. Bufotenine.
951c. DET (Diethyltryptamine).
952d. DMT (Dimethyltryptamine).
953e. MET (N-Methyl-N-ethyltryptamine).
954f. DALT (N,N-Diallyltryptamine).
955g. EiPT (N-Ethyl-N-isopropyltryptamine).
956h. MiPT (N-Methyl-N-isopropyltryptamine).
957i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
958j. 5-Hydroxy-N-methyltryptamine.
959k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
960l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
961m. Methyltryptamine.
962n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
963o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
964p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
965q. DiPT (N,N-Diisopropyltryptamine).
966r. DPT (N,N-Dipropyltryptamine).
967s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
968t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
969u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).
970v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).
971w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).
972x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).
973y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N
974isopropyltryptamine).
975z. Methyl-alpha-ethyltryptamine.
976aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),
977
978which does not include tryptamine, psilocyn as described in
979subparagraph 34., or psilocybin as described in subparagraph 33.
980195. Substituted Phenylcyclohexylamines.—Unless
981specifically excepted or unless listed in another schedule, or
982contained within a pharmaceutical product approved by the United
983States Food and Drug Administration, any material, compound,
984mixture, or preparation containing a phenylcyclohexylamine
985structure, with or without any substitution on the phenyl ring,
986any substitution on the cyclohexyl ring, any replacement of the
987phenyl ring with a thiophenyl or benzothiophenyl ring, with or
988without substitution on the amine with alkyl, dialkyl, or alkoxy
989substituents, inclusion of the nitrogen in a cyclic structure,
990or any combination of the above, including, but not limited to:
991a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
992(Benocyclidine).
993b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
994of phencyclidine).
995c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine
996analog of phencyclidine).
997d. PCPr (Phenylcyclohexylpropylamine).
998e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene
999analog of phencyclidine).
 1000  f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).
 1001  g. PCMPA (Phenylcyclohexyl(methoxypropylamine)).
 1002  h. Methoxetamine.
 1003  i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
 1004  j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).
 1005  k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
 1006  l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
 1007  m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
 1008  n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
 1009  o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).
 1010  p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
 1011  q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).
 1012  r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).
 1013  196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2
 1014  piperidinylidene]-benzenesulfonamide.
 1015  197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2
 1016  piperidinylidene]-benzenesulfonamide.
 1017  198. AH-7921, 3,4-dichloro-N-[[1
 1018  (dimethylamino)cyclohexyl]methyl]-benzamide.
 1019  199. U47700, trans-3,4-dichloro-N-[2
 1020  (dimethylamino)cyclohexyl]-N-methyl-benzamide.
 1021  200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,
 1022  dihydrochloride.
 1023  Section 4. Paragraph (i) of subsection (1) of section
 1024  893.13, Florida Statutes, is amended to read:
 1025  893.13 Prohibited acts; penalties.—
 1026  (1)
 1027  (i) Except as authorized by this chapter, a person commits
 1028  a felony of the first degree, punishable as provided in s.
 1029  775.082, s. 775.083, or s. 775.084, and must be sentenced to a
 1030  mandatory minimum term of imprisonment of 3 years, if:
 1031  1. The person sells, manufactures, or delivers, or
 1032  possesses with intent to sell, manufacture, or deliver, any of
 1033  the following:
 1034  a. Alfentanil, as described in s. 893.03(2)(b)1.;
 1035  b. Carfentanil, as described in s. 893.03(2)(b)6.;
 1036  c. Fentanyl, as described in s. 893.03(2)(b)9.;
 1037  d. Sufentanil, as described in s. 893.03(2)(b)30.;
 1038  e. A fentanyl derivative, as described in s.
 1039  893.03(1)(a)63.;
 1040  f. Xylazine, as described in s. 893.03(1)(c)37.;
 1041  g.f. A controlled substance analog, as described in s.
 1042  893.0356, of any substance described in sub-subparagraphs a.-f.
 1043  sub-subparagraphs a.-e.; or
 1044  h.g. A mixture containing any substance described in sub
 1045  subparagraphs a.-g. sub-subparagraphs a.-f.; and
 1046  2. The substance or mixture listed in subparagraph 1. is in
 1047  a form that resembles, or is mixed, granulated, absorbed, spray
 1048  dried, or aerosolized as or onto, coated on, in whole or in
 1049  part, or solubilized with or into, a product, when such product
 1050  or its packaging further has at least one of the following
 1051  attributes:
 1052  a. Resembles the trade dress of a branded food product,
 1053  consumer food product, or logo food product;
 1054  b. Incorporates an actual or fake registered copyright,
 1055  service mark, or trademark;
 1056  c. Resembles candy, cereal, a gummy, a vitamin, or a
 1057  chewable product, such as a gum or gelatin-based product; or
 1058  d. Contains a cartoon character imprint.
 1059  Section 5. Paragraph (c) of subsection (1) of section
 1060  893.135, Florida Statutes, is amended to read:
 1061  893.135 Trafficking; mandatory sentences; suspension or
 1062  reduction of sentences; conspiracy to engage in trafficking.—
 1063  (1) Except as authorized in this chapter or in chapter 499
 1064  and notwithstanding the provisions of s. 893.13:
 1065  (c)1. A person who knowingly sells, purchases,
 1066  manufactures, delivers, or brings into this state, or who is
 1067  knowingly in actual or constructive possession of, 4 grams or
 1068  more of any morphine, opium, hydromorphone, or any salt,
 1069  derivative, isomer, or salt of an isomer thereof, including
 1070  heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or
 1071  (3)(c)4., or 4 grams or more of any mixture containing any such
 1072  substance, but less than 30 kilograms of such substance or
 1073  mixture, commits a felony of the first degree, which felony
 1074  shall be known as “trafficking in illegal drugs,” punishable as
 1075  provided in s. 775.082, s. 775.083, or s. 775.084. If the
 1076  quantity involved:
 1077  a. Is 4 grams or more, but less than 14 grams, such person
 1078  shall be sentenced to a mandatory minimum term of imprisonment
 1079  of 3 years and shall be ordered to pay a fine of $50,000.
 1080  b. Is 14 grams or more, but less than 28 grams, such person
 1081  shall be sentenced to a mandatory minimum term of imprisonment
 1082  of 15 years and shall be ordered to pay a fine of $100,000.
 1083  c. Is 28 grams or more, but less than 30 kilograms, such
 1084  person shall be sentenced to a mandatory minimum term of
 1085  imprisonment of 25 years and shall be ordered to pay a fine of
 1086  $500,000.
 1087  2. A person who knowingly sells, purchases, manufactures,
 1088  delivers, or brings into this state, or who is knowingly in
 1089  actual or constructive possession of, 28 grams or more of
 1090  hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as
 1091  described in s. 893.03(2)(a)1.g., or any salt thereof, or 28
 1092  grams or more of any mixture containing any such substance,
 1093  commits a felony of the first degree, which felony shall be
 1094  known as “trafficking in hydrocodone,” punishable as provided in
 1095  s. 775.082, s. 775.083, or s. 775.084. If the quantity involved:
 1096  a. Is 28 grams or more, but less than 50 grams, such person
 1097  shall be sentenced to a mandatory minimum term of imprisonment
 1098  of 3 years and shall be ordered to pay a fine of $50,000.
 1099  b. Is 50 grams or more, but less than 100 grams, such
 1100  person shall be sentenced to a mandatory minimum term of
 1101  imprisonment of 7 years and shall be ordered to pay a fine of
 1102  $100,000.
 1103  c. Is 100 grams or more, but less than 300 grams, such
 1104  person shall be sentenced to a mandatory minimum term of
 1105  imprisonment of 15 years and shall be ordered to pay a fine of
 1106  $500,000.
 1107  d. Is 300 grams or more, but less than 30 kilograms, such
 1108  person shall be sentenced to a mandatory minimum term of
 1109  imprisonment of 25 years and shall be ordered to pay a fine of
 1110  $750,000.
 1111  3. A person who knowingly sells, purchases, manufactures,
 1112  delivers, or brings into this state, or who is knowingly in
 1113  actual or constructive possession of, 7 grams or more of
 1114  oxycodone, as described in s. 893.03(2)(a)1.q., or any salt
 1115  thereof, or 7 grams or more of any mixture containing any such
 1116  substance, commits a felony of the first degree, which felony
 1117  shall be known as “trafficking in oxycodone,” punishable as
 1118  provided in s. 775.082, s. 775.083, or s. 775.084. If the
 1119  quantity involved:
 1120  a. Is 7 grams or more, but less than 14 grams, such person
 1121  shall be sentenced to a mandatory minimum term of imprisonment
 1122  of 3 years and shall be ordered to pay a fine of $50,000.
 1123  b. Is 14 grams or more, but less than 25 grams, such person
 1124  shall be sentenced to a mandatory minimum term of imprisonment
 1125  of 7 years and shall be ordered to pay a fine of $100,000.
 1126  c. Is 25 grams or more, but less than 100 grams, such
 1127  person shall be sentenced to a mandatory minimum term of
 1128  imprisonment of 15 years and shall be ordered to pay a fine of
 1129  $500,000.
 1130  d. Is 100 grams or more, but less than 30 kilograms, such
 1131  person shall be sentenced to a mandatory minimum term of
 1132  imprisonment of 25 years and shall be ordered to pay a fine of
 1133  $750,000.
 1134  4.a. A person who knowingly sells, purchases, manufactures,
 1135  delivers, or brings into this state, or who is knowingly in
 1136  actual or constructive possession of, 4 grams or more of:
 1137  (I) Alfentanil, as described in s. 893.03(2)(b)1.;
 1138  (II) Carfentanil, as described in s. 893.03(2)(b)6.;
 1139  (III) Fentanyl, as described in s. 893.03(2)(b)9.;
 1140  (IV) Sufentanil, as described in s. 893.03(2)(b)30.;
 1141  (V) A fentanyl derivative, as described in s.
 1142  893.03(1)(a)63.;
 1143  (VI) A controlled substance analog, as described in s.
 1144  893.0356, of any substance described in sub-sub-subparagraphs
 1145  (I)-(V); or
 1146  (VII) A mixture containing any substance described in sub
 1147  sub-subparagraphs (I)-(VI),
 1148
 1149  commits a felony of the first degree, which felony shall be
 1150  known as “trafficking in dangerous fentanyl or fentanyl
 1151  analogues,” punishable as provided in s. 775.082, s. 775.083, or
 1152  s. 775.084.
 1153  b. If the quantity involved under sub-subparagraph a.:
 1154  (I) Is 4 grams or more, but less than 14 grams, such person
 1155  shall be sentenced to a mandatory minimum term of imprisonment
 1156  of 7 years, and shall be ordered to pay a fine of $50,000.
 1157  (II) Is 14 grams or more, but less than 28 grams, such
 1158  person shall be sentenced to a mandatory minimum term of
 1159  imprisonment of 20 years, and shall be ordered to pay a fine of
 1160  $100,000.
 1161  (III) Is 28 grams or more, such person shall be sentenced
 1162  to a mandatory minimum term of imprisonment of 25 years, and
 1163  shall be ordered to pay a fine of $500,000.
 1164  c. A person 18 years of age or older who violates sub
 1165  subparagraph a. by knowingly selling or delivering to a minor at
 1166  least 4 grams of a substance or mixture listed in sub
 1167  subparagraph a. shall be sentenced to a mandatory minimum term
 1168  of not less than 25 years and not exceeding life imprisonment,
 1169  and shall be ordered to pay a fine of $1 million if the
 1170  substance or mixture listed in sub-subparagraph a. is in a form
 1171  that resembles, or is mixed, granulated, absorbed, spray-dried,
 1172  or aerosolized as or onto, coated on, in whole or in part, or
 1173  solubilized with or into, a product, when such product or its
 1174  packaging further has at least one of the following attributes:
 1175  (I) Resembles the trade dress of a branded food product,
 1176  consumer food product, or logo food product;
 1177  (II) Incorporates an actual or fake registered copyright,
 1178  service mark, or trademark;
 1179  (III) Resembles candy, cereal, a gummy, a vitamin, or a
 1180  chewable product, such as a gum or gelatin-based product; or
 1181  (IV) Contains a cartoon character imprint.
 1182  5. A person who knowingly sells, purchases, manufactures,
 1183  delivers, or brings into this state, or who is knowingly in
 1184  actual or constructive possession of, 30 kilograms or more of
 1185  any morphine, opium, oxycodone, hydrocodone, codeine,
 1186  hydromorphone, or any salt, derivative, isomer, or salt of an
 1187  isomer thereof, including heroin, as described in s.
 1188  893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or
 1189  more of any mixture containing any such substance, commits the
 1190  first degree felony of trafficking in illegal drugs. A person
 1191  who has been convicted of the first degree felony of trafficking
 1192  in illegal drugs under this subparagraph shall be punished by
 1193  life imprisonment and is ineligible for any form of
 1194  discretionary early release except pardon or executive clemency
 1195  or conditional medical release under s. 947.149. However, if the
 1196  court determines that, in addition to committing any act
 1197  specified in this paragraph:
 1198  a. The person intentionally killed an individual or
 1199  counseled, commanded, induced, procured, or caused the
 1200  intentional killing of an individual and such killing was the
 1201  result; or
 1202  b. The person’s conduct in committing that act led to a
 1203  natural, though not inevitable, lethal result,
 1204
 1205  such person commits the capital felony of trafficking in illegal
 1206  drugs, punishable as provided in ss. 775.082 and 921.142. A
 1207  person sentenced for a capital felony under this paragraph shall
 1208  also be sentenced to pay the maximum fine provided under
 1209  subparagraph 1.
 1210  6. A person who knowingly brings into this state 60
 1211  kilograms or more of any morphine, opium, oxycodone,
 1212  hydrocodone, codeine, hydromorphone, or any salt, derivative,
 1213  isomer, or salt of an isomer thereof, including heroin, as
 1214  described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or
 1215  60 kilograms or more of any mixture containing any such
 1216  substance, and who knows that the probable result of such
 1217  importation would be the death of a person, commits capital
 1218  importation of illegal drugs, a capital felony punishable as
 1219  provided in ss. 775.082 and 921.142. A person sentenced for a
 1220  capital felony under this paragraph shall also be sentenced to
 1221  pay the maximum fine provided under subparagraph 1.
 1222  7. A person who knowingly sells, purchases, manufactures,
 1223  delivers, or brings into this state, or who is knowingly in
 1224  actual or constructive possession of, 28 grams or more of
 1225  xylazine, as described in s. 893.03(1)(c)37., or any salt
 1226  thereof, or 28 grams or more of any mixture containing any such
 1227  substance, commits a felony of the first degree, which felony
 1228  shall be known as “trafficking in xylazine,” punishable as
 1229  provided in s. 775.082, s. 775.083, or s. 775.084. If the
 1230  quantity involved:
 1231  a. Is 28 grams or more, but less than 100 grams, such
 1232  person shall be sentenced to a mandatory minimum term of
 1233  imprisonment of 3 years and shall be ordered to pay a fine of
 1234  $50,000.
 1235  b. Is 100 grams or more, but less than 200 grams, such
 1236  person shall be sentenced to a mandatory minimum term of
 1237  imprisonment of 7 years and shall be ordered to pay a fine of
 1238  $100,000.
 1239  c. Is 200 grams or more, such person shall be sentenced to
 1240  a mandatory minimum term of imprisonment of 25 years and shall
 1241  be ordered to pay a fine of $500,000.
 1242  Section 6. Except as otherwise expressly provided in this
 1243  act and except for this section, which shall take effect upon
 1244  this act becoming a law, this act shall take effect October 1,
 1245  2026.